AEON Biopharma (AEON) Cash from Operations (2021 - 2025)
AEON Biopharma (AEON) posted Cash from Operations of 4712000.0 for Q4 2025, down 81.51% sequentially from 2596000.0 in Q3 2025, and down 658.78% YoY from 843271.47 in Q4 2024.
AEON Biopharma (AEON) Cash from Operations (2021 - 2025) Analysis & Trends
AEON Biopharma has reported Cash from Operations for 5 years, with the latest figure at 4712000.0 in Q4 2025.
- Quarterly Cash from Operations fell 658.78% year-over-year to 4712000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 17308000.0 (up 46.58% YoY) and the FY2025 annual result came in at 17308000.0, up 14.71% from the prior year.
- Cash from Operations declined to 4712000.0 in Q4 2025 per AEON's latest filing, from 2596000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 158485.0 in Q2 2022 and troughed at 26559846.0 in Q3 2022.
- A 5-year average of 5755458.12 and a median of 2596000.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations sank 8064.35% in 2022, then jumped 74.24% in 2025.
- Over 5 years, Cash from Operations stood at 162633.0 in 2021, then plunged by 5098.21% to 8454000.0 in 2022, then sank by 78.15% to 15061000.0 in 2023, then surged by 95.88% to 621000.0 in 2024, then plunged by 658.78% to 4712000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 4712000.0, 2596000.0, and 2091000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 326.72 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -88.83 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 728.46 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.27 Mn |
| 10 | AEON Biopharma | 10.06 Mn | 6.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.71 Mn |
| Dec 31, 2025 | -4.71 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | -2.09 Mn |
| Jun 30, 2025 | -2.09 Mn |
| Mar 31, 2025 | -7.91 Mn |
| Mar 31, 2025 | -7.91 Mn |
| Dec 31, 2024 | -621,000.00 |
| Dec 31, 2024 | -621,000.00 |
| Jun 30, 2024 | -8.12 Mn |
| Jun 30, 2024 | -8.12 Mn |
| Mar 31, 2024 | -8.60 Mn |
| Mar 31, 2024 | -8.60 Mn |
| Sep 30, 2023 | -15.06 Mn |
| Sep 30, 2023 | -15.06 Mn |
| Mar 31, 2023 | -11.06 Mn |
| Mar 31, 2023 | -11.06 Mn |
| Dec 31, 2022 | -8.45 Mn |
| Dec 31, 2022 | -8.45 Mn |